2024 Global Cyclospora Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies

August 2024 | - | ID: 23AFD7F8627AEN
Venture Planning Group

Abstracts

The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:& Hospitals& Commercial/Private Labs& Physician Offices& Public Health LabsFor each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Cyclospora tests.Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.Contains 191 pages and 7 tables

Contents

I. Introduction
II. Worldwide Test Overview,
Technologies and Instrumentation
A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. Country Analyses: Sales and Volume Forecasts
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- Wako

---

---

More Publications

2018 World Immunoprotein Testing Market: Americas, EMEA, APAC—A 75-Country Analysis--Supplier Shares, Segment Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Emerging Opportunities US$ 14,500.00 October 2018 -

2015 Spain Sales and Market Shares of Major Clinical Chemistry and Immunodiagnostic Product Suppliers US$ 1,800.00 June 2015 73 pages

hs-CRP Diagnostics Market: Test Volume and Sales Forecasts by Country, 2019-2023--US, Europe, Japan US$ 750.00 August 2019 -

Succeeding in the Global Clinical Chemistry and Immunodiagnostics Market, 2019-2023: US, Europe, Japan--Analyzers and Reagents-- Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities US$ 28,500.00 June 2019 1200 pages

2017 Global Fungicides Market: Future Horizons and Growth Strategies--Business Assessments of Leading Suppliers US$ 6,660.00 March 2017 378 pages